Innovative Transapical Approach for Double Aortic and Mitral Valve inValve Replacement A Case Study

Introduction

Double valves-in-valves (VIV) replacement through a single transapical access is an emerging technique for high-risk patients with contraindications for transseptal access. This case study highlights the successful execution of a double VIV procedure under cerebral angiography control, ensuring minimized thrombus embolism risks.

Case Summary

A 72-year-old male patient with a history of aortic and mitral bioprosthetic valve replacement in 2010 presented with severe dyspnea (NYHA Class IV). Diagnostic imaging confirmed stenotic bioprostheses and persistent left atrial thrombus despite optimal anticoagulation. Due to transseptal access contraindications, the heart team opted for a transapical double VIV replacement strategy.

Key Findings

  • Transapical VIV Procedure:
    • Aortic VIV implantation using Edwards Sapien 3 (26 mm).
    • Mitral VIV implantation using Edwards Sapien 3 (29 mm).
    • Cerebral angiography post-implantation confirmed no cerebral artery occlusion.
  • Right Ventricle Laceration Management:
    • Urgent ECMO implantation was successfully performed to stabilize the patient.
  • Follow-up Outcomes:
    • The patient was discharged symptom-free after 14 days.
    • At the 6-month follow-up, stable valve gradients and improved left ventricular ejection fraction (45%) were observed.

Clinical Implications and Expert Insights

Read the Full Study

Further Reading

Join the Conversation

Disclaimer: This content is generated using AI assistance and should be reviewed for accuracy and compliance before considering this article and its contents as a reference. Any mishaps or grievances raised due to the reusing of this material will not be handled by the author of this article.